Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

Explore how AI transforms cancer drug discovery by predicting proteins and accelerating drug candidate identification and ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

Research Institute today announced they have entered into an agreement with Janssen Research & Development, LLC, a Johnson & ...

The global artificial intelligence in clinical trials market , valued at US$1.20 billion in 2023, is forecasted to grow at a ...

GATC Health is redefining the landscape of Post-Traumatic Stress Disorder (PTSD) treatment and drug discovery through its ...

Susan Sharfstein, a professor at UAlbany's College of Nanotechnology, Science and Engineering, partners with DeepSeq.AI on a ...